1. Home
  2. HON vs BMY Comparison

HON vs BMY Comparison

Compare HON & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Honeywell International Inc.

HON

Honeywell International Inc.

HOLD

Current Price

$223.66

Market Cap

141.8B

Sector

Industrials

ML Signal

HOLD

Logo Bristol-Myers Squibb Company

BMY

Bristol-Myers Squibb Company

HOLD

Current Price

$57.70

Market Cap

123.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HON
BMY
Founded
1885
1887
Country
United States
United States
Employees
N/A
32500
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
141.8B
123.7B
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
HON
BMY
Price
$223.66
$57.70
Analyst Decision
Buy
Buy
Analyst Count
13
16
Target Price
$252.23
$61.81
AVG Volume (30 Days)
3.2M
9.8M
Earning Date
04-23-2026
04-30-2026
Dividend Yield
2.09%
4.25%
EPS Growth
N/A
N/A
EPS
7.36
N/A
Revenue
$36,529,000,000.00
N/A
Revenue This Year
$6.80
N/A
Revenue Next Year
$5.86
N/A
P/E Ratio
$30.98
$17.26
Revenue Growth
12.92
N/A
52 Week Low
$179.36
$42.52
52 Week High
$248.18
$62.89

Technical Indicators

Market Signals
Indicator
HON
BMY
Relative Strength Index (RSI) 40.67 43.26
Support Level $220.02 $56.45
Resistance Level $242.47 $62.47
Average True Range (ATR) 4.49 1.27
MACD -0.03 -0.04
Stochastic Oscillator 27.11 23.20

Price Performance

Historical Comparison
HON
BMY

About HON Honeywell International Inc.

Honeywell traces its roots to 1885 with Albert Butz's firm, Butz Thermo-Electric Regulator, which produced a predecessor to the modern thermostat. Other inventions by Honeywell include biodegradable detergent and autopilot. Today, Honeywell is a global multi-industry behemoth with one of the largest installed bases of equipment. It operates through four business segments: aerospace technologies, industrial automation, energy and sustainability solutions, and building automation. Recently, Honeywell has made several portfolio changes to focus on fewer end markets and align with a set of secular growth trends. The firm is working diligently to expand its installed base, deriving around one third of its revenue from recurring aftermarket services.

About BMY Bristol-Myers Squibb Company

Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Share on Social Networks: